SEC 13F Intelligence

Boxer Capital, LLC / RETAEUR

Boxer Capital, LLC’s Reata Pharmaceuticals Inc Position

Does Boxer Capital, LLC own Reata Pharmaceuticals Inc (RETAEUR)? Not currently — the last reported position was 1.43M shares worth $145,803 in Q2 2023; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$145,803
Q2 2023
Shares
1.43M
% of Portfolio
+6.76%
Quarters Held
7
position exited

Position History RETAEUR

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’22: $41MQ1 ’22Q2 ’22: $38MQ2 ’22Q3 ’22: $31MQ3 ’22Q4 ’22: $47MQ4 ’22Q1 ’23: $111,832Q1 ’23Q2 ’23: $145,803Q2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20231.43M$145,803+6.76%
Q1 20231.23M$111,832+5.49%
Q4 20221.23M$47M+2.46%
Q3 20221.24M$31M+1.75%
Q2 20221.24M$38M+2.38%
Q1 20221.24M$41M+2.09%
Q4 201850.0K$3M+0.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of RETAEUR.